Page last updated: 2024-10-26

doxepin and Carcinoma, Squamous Cell

doxepin has been researched along with Carcinoma, Squamous Cell in 1 studies

Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Epstein, JB1
Epstein, JD1
Epstein, MS1
Oien, H1
Truelove, EL1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of Controlled-release Oxycodone to Control Chemoradiotherapy-induced Moderate or Severe Oral Mucositis Pain in Nasopharyngeal Carcinoma Patients[NCT03045484]70 participants (Anticipated)Interventional2016-05-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for doxepin and Carcinoma, Squamous Cell

ArticleYear
Management of pain in cancer patients with oral mucositis: follow-up of multiple doses of doxepin oral rinse.
    Journal of pain and symptom management, 2007, Volume: 33, Issue:2

    Topics: Adult; Antidepressive Agents, Tricyclic; Carcinoma, Squamous Cell; Doxepin; Female; Follow-Up Studie

2007